$83.15
Amdocs is a software - infrastructure business based in the US. Amdocs shares (DOX) are listed on the NASDAQ and all prices are listed in US Dollars. Amdocs employs 29,000 staff and has a trailing 12-month revenue of around $5 billion.
Our top picks for where to buy Amdocs stock
How to buy Amdocs stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – DOX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Amdocs stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Amdocs stock price (NASDAQ: DOX)
Use our graph to track the performance of DOX stocks over time.Amdocs shares at a glance
Latest market close | $83.05 |
---|---|
52-week range | $73.96 - $94.63 |
50-day moving average | $79.17 |
200-day moving average | $85.22 |
Wall St. target price | $99.25 |
PE ratio | 18.5381 |
Dividend yield | $1.784 (2.32%) |
Earnings per share (TTM) | $4.46 |
Is it a good time to buy Amdocs stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Amdocs price performance over time
Historical closes compared with the close of $83.05 from 2024-07-23
1 week (2024-07-18) | -0.84% |
---|---|
1 month (2024-06-25) | 6.08% |
3 months (2024-04-25) | -3.02% |
6 months (2024-01-25) | -10.06% |
1 year (2023-07-25) | -13.82% |
---|---|
2 years (2022-07-25) | -3.65% |
3 years (2021-07-23) | 6.62% |
5 years (2019-07-25) | 34.74% |
Is Amdocs stock undervalued or overvalued?
Valuing Amdocs stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amdocs's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Amdocs's P/E ratio
Amdocs's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, Amdocs shares trade at around 19x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Amdocs's PEG ratio
Amdocs's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0095. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Amdocs's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Amdocs's EBITDA
Amdocs's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $931.7 million.
The EBITDA is a measure of a Amdocs's overall financial performance and is widely used to measure a its profitability.
Amdocs financials
Revenue TTM | $5 billion |
---|---|
Operating margin TTM | 15.16% |
Gross profit TTM | $1.6 billion |
Return on assets TTM | 7.2% |
Return on equity TTM | 14.71% |
Profit margin | 10.62% |
Book value | $30.58 |
Market Capitalization | $9.6 billion |
TTM: trailing 12 months
Amdocs share dividends
Dividend payout ratio: 29.92% of net profits
Recently Amdocs has paid out, on average, around 29.92% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.32% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Amdocs shareholders could enjoy a 2.32% return on their shares, in the form of dividend payments. In Amdocs's case, that would currently equate to about $1.784 per share.
While Amdocs's payout ratio might seem fairly standard, it's worth remembering that Amdocs may be investing much of the rest of its net profits in future growth.
Amdocs's most recent dividend payout was on 25 July 2024. The latest dividend was paid out to all shareholders who bought their shares by 27 June 2024 (the "ex-dividend date").
Amdocs share price volatility
Over the last 12 months, Amdocs's shares have ranged in value from as little as $73.9551 up to $94.6292. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amdocs's is 0.744. This would suggest that Amdocs's shares are less volatile than average (for this exchange).
Amdocs overview
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers. It also offers AI-powered, cloud-native, and home operating systems; data intelligence solutions and applications; end-to-end application development and maintenance services; and ongoing maintenance services. In addition, the company provides a line of services designed for various stages of a service provider's lifecycle includes consulting, delivery, quality engineering, operations, systems integration, network services, experience-driven services, data, cloud, and content services; managed services comprising application development, modernization and maintenance, IT and infrastructure services, testing and professional services that are designed to assist customers in the selection, implementation, operation, management, and maintenance of IT systems. It serves to the communications, entertainment, and media industry service providers, as well as mobile virtual network operators. Amdocs Limited was founded in 1988 and is headquartered in Saint Louis, Missouri.
Frequently asked questions
nullWhat percentage of Amdocs is owned by institutions?
Currently 97.456% of Amdocs shares are held by institutions. How many people work for Amdocs?
Latest data suggests 29,000 work at Amdocs. When does the fiscal year end for Amdocs?
Amdocs's fiscal year ends in September. Where is Amdocs based?
Amdocs's address is: 625 Maryville Centre Drive, Saint Louis, MO, United States, 63141 What is Amdocs's ISIN number?
Amdocs's international securities identification number is: USG026021034 What is Amdocs's CUSIP number?
Amdocs's Committee on Uniform Securities Identification Procedures number is: G02602103
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 top semiconductor stocks to buy in 2024
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question